Citation Impact
Citing Papers
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
2006
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
2013
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Bosentan Therapy in Patients With Eisenmenger Syndrome
2006
The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis.
2006
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Photoactivatable CO release from engineered protein crystals to modulate NF-κB activation
2016 StandoutNobel
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis
2009
Volume spirometers need automated internal temperature sensors.
1994
Effect of a Microaerosol Barrier Filter on the Measurement of Lung Function
1995
The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease
2013
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
2009
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
2015
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
2017
Idiopathic pulmonary fibrosis
2017 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
2014
Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
2007
Reference Ranges for Spirometry Across All Ages
2007
Age- and height-based prediction bias in spirometry reference equations
2011
Prognostic Implications of Histologic Patterns in Multiple Surgical Lung Biopsies From Patients With Idiopathic Interstitial Pneumonias
2004
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
2014
Lungs in thalassaemia major patients receiving regular transfusion
1996
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
2010
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
The β-Thalassemias
1999 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
2015
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study
2007
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
2012
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis
2015
Laboratory evaluation of a filter for the control of cross-infection during pulmonary function testing
1992
Pediatric Pulmonary Hypertension
2013
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2007
Idiopathic Pulmonary Fibrosis
2007
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
2007
The efficacy of filters used in respiratory function apparatus
1995
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
2007
The biology and function of fibroblasts in cancer
2016 Standout
Standardisation of spirometry
2005 Standout
Systemic sclerosis
2017 Standout
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
2016
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
2005
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Prevalence and prognosis of unclassifiable interstitial lung disease
2012
Quantitative Computed Tomography Imaging of Interstitial Lung Diseases
2013
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
2016
Normal spirometric reference values for Omani children and adolescents
2004
Spirometric reference values for white European children and adolescents: Polgar revisited
1995
Sarcoidosis
2013 Standout
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program
2011
CO and NO in medicine
2007
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
2010
Asthma
2017 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Interstitial Lung Disease in Systemic Sclerosis
2008 Standout
General considerations for lung function testing
2005 Standout
Assessment of Prognosis of Patients With Idiopathic Pulmonary Fibrosis by Computer-aided Analysis of CT Images
2009
The natural history of progressive fibrosing interstitial lung diseases
2019
Cross-sectional and Longitudinal Spirometry in Children and Adolescents
2008
The impact of emphysema in pulmonary fibrosis
2013
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
2004
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
2005
The single breath transfer factor (Tl,co ) and the transfer coefficient (Kco ): a window onto the pulmonary microcirculation
2003
Interpretative strategies for lung function tests
2005 Standout
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
2013
Idiopathic pulmonary fibrosis
2017 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Down patients with Eisenmenger syndrome: Is bosentan treatment an option?
2008
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Bacterial colonization as a potential source of nosocomial respiratory infections in two types of spirometer
1996
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
2009
Age‐ and size‐related reference ranges: A case study of spirometry through childhood and adulthood
2008
Spirometric values in Tunisian children: Relationship with pubertal status
2007
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
2014
Pirfenidone in idiopathic pulmonary fibrosis
2009 Standout
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Natural history of idiopathic pulmonary fibrosis
2015
Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis
2013
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
2013
Idiopathic Pulmonary Fibrosis*
2005
Classification and Natural History of the Idiopathic Interstitial Pneumonias
2006
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis
2006
Pathogenesis of obstructive sleep apnea
2005
Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study
2010
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Major lung complications of systemic sclerosis
2018
Idiopathic pulmonary fibrosis
2011 Standout
Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
2007
Metal Carbonyls: A New Class of Pharmaceuticals?
2003
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
2013
The Role of Oxidative Stress in Chronic Obstructive Pulmonary Disease
2004
Heme oxygenase-1 and carbon monoxide in pulmonary medicine
2003
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression
2010
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
2016
Resting and exercise physiology in interstitial lung diseases
2004
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
2012
Spirometric Reference Values in Tunisian Children
2004
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
2013
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
2011
Lung Function Reference Values in Chinese Children and Adolescents in Hong Kong
2000
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
2019
Six-Minute Walk, Maximal Exercise Tests
2005
Fibrotic Idiopathic Interstitial Pneumonia
2003
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
2011
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
2011
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
2017
Increased Expression of Heme Oxygenase (HO)-1 in Alveolar Spaces and HO-2 in Alveolar Walls of Smokers
2001
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
2017
All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials
2014
The Relationship between Individual Histologic Features and Disease Progression in Idiopathic Pulmonary Fibrosis
2002
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2011
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Primary Ciliary Dyskinesia
2003
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
2005
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways
2016
Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
2017
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Measurement of exhaled breath temperature in science and clinical practice
2012
Sensitive Wearable Temperature Sensor with Seamless Monolithic Integration
2019 Standout
Lung transplantation in IIP : A review
2015
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Enhancement of ICRP's Lung Deposition Model for Pathogenic Bioaerosols
2014
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
2017
Non-steroid agents for idiopathic pulmonary fibrosis
2010
Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials
2018
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Cryptogenic fibrosing alveolitis with preserved lung volumes
1997
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
Airborne transmission of respiratory viruses
2021 StandoutScience
Idiopathic Pulmonary Fibrosis
2018 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of D. Cramer being referenced
Optimal scoring of serial change on chest radiography in sarcoidosis.
2011
Fibrosing alveolitis in systemic sclerosis: Indices of lung function in relation to extent of disease on computed tomography
1997
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
2003
Lung function testing and AIDS
1989
Safety and tolerability of bosentan in adults with Eisenmenger physiology
2004
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression
2007
Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography.
1997
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
2009
Effect of pattern and severity of respiratory muscle weakness on carbon monoxide gas transfer and lung volumes
2002
Exhaled Ethane Is Elevated in Cystic Fibrosis and Correlates with Carbon Monoxide Levels and Airway Obstruction
2000
Idiopathic Pulmonary Fibrosis
2003
Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation.
1992
Fibrosing alveolitis in systemic sclerosis: Indices of lung function in relation to extent of disease on computed tomography
1997
Temperature corrections in routine spirometry.
1984
Lung function in white children aged 4 to 19 years: II--Single breath analysis and plethysmography.
1993
Lung function in white children aged 4 to 19 years: I--Spirometry.
1993